ImmunoPrecise Antibodies Ltd (IPA)
0.46
-0.02
(-3.62%)
USD |
NASDAQ |
Nov 14, 16:00
0.50
+0.04
(+8.70%)
After-Hours: 20:00
ImmunoPrecise Antibodies Shareholders Equity (Quarterly): 23.72M for July 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
July 31, 2024 | 23.72M |
April 30, 2024 | 24.82M |
January 31, 2024 | 37.17M |
October 31, 2023 | 37.62M |
July 31, 2023 | 40.62M |
April 30, 2023 | 42.32M |
January 31, 2023 | 45.63M |
October 31, 2022 | 45.37M |
July 31, 2022 | 51.10M |
April 30, 2022 | 58.18M |
January 31, 2022 | 37.37M |
October 31, 2021 | 41.07M |
July 31, 2021 | 44.43M |
April 30, 2021 | 46.37M |
January 31, 2021 | 25.24M |
October 31, 2020 | 23.33M |
July 31, 2020 | 14.85M |
April 30, 2020 | 10.78M |
January 31, 2020 | 10.93M |
October 31, 2019 | 11.09M |
July 31, 2019 | 11.94M |
April 30, 2019 | 13.43M |
January 31, 2019 | 15.11M |
October 31, 2018 | 15.73M |
July 31, 2018 | 9.401M |
Date | Value |
---|---|
April 30, 2018 | 9.890M |
January 31, 2018 | 8.223M |
October 31, 2017 | 8.258M |
July 31, 2017 | 1.979M |
April 30, 2017 | 2.268M |
January 31, 2017 | 2.925M |
September 30, 2016 | 0.2125M |
June 30, 2016 | -0.1684M |
March 31, 2016 | -0.18M |
December 31, 2015 | -0.1732M |
September 30, 2015 | -0.1638M |
June 30, 2015 | -0.1678M |
March 31, 2015 | -0.1696M |
December 31, 2014 | -0.1796M |
September 30, 2014 | -0.1964M |
June 30, 2014 | -0.1745M |
March 31, 2014 | -0.143M |
December 31, 2013 | -0.1514M |
September 30, 2013 | -0.0993M |
June 30, 2013 | -0.2391M |
March 31, 2013 | -0.2279M |
December 31, 2012 | -0.2168M |
September 30, 2012 | -0.1671M |
June 30, 2012 | -0.1417M |
March 31, 2012 | -0.1267M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.78M
Minimum
Apr 2020
58.18M
Maximum
Apr 2022
34.78M
Average
37.62M
Median
Oct 2023
Shareholders Equity (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 388.00M |
Edesa Biotech Inc | 2.867M |
Lexaria Bioscience Corp | 10.12M |
Xenon Pharmaceuticals Inc | 844.05M |
ESSA Pharma Inc | 128.86M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 42.81M |
Total Liabilities (Quarterly) | 19.09M |
Debt to Equity Ratio | 0.0791 |
Current Ratio | 0.9862 |
Net Debt Paydown Yield | -1.74% |